Schmidt P J Investment Management Inc. Raised its stake in stocks of CVS Health Corp

Schmidt P J Investment Management Inc. Raised its stake in stocks of CVS Health Corp (NYSE:CVS) by means of 48.9% for the duration of the first quarter, in step with its maximum latest disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,576 shares of the pharmacy operator’s inventory after shopping for an extra 7,410 stocks throughout the duration. Schmidt P J Investment Management Inc.’s holdings in CVS Health Corp were well worth $1,772,000 as of its maximum recent SEC filing.
A quantity of different hedge funds have additionally added to or decreased their stakes within the
inventory. Palo Capital Inc. Raised its stake in CVS Health Corp through 47.9% within the first sector. Palo Capital Inc. Now owns 30,482 stocks of the drugstore operator’s inventory worth $2,393,000 after buying an extra nine,870 stocks within the closing region. Breton Hill Capital Ltd. Obtained a new stake in CVS Health Corp at some point of the first zone worth about $917,000. Taylor Cottrill Erickson & Associates Inc. Raised its stake in CVS Health Corp by using forty five.5% within the first area. Taylor Cottrill Erickson & Associates Inc. Now owns 8,067 shares of the drugstore operator’s stock worth $633,000 after shopping for a further 2,523 shares in the ultimate zone. Leavell Investment Management Inc. Raised its stake in CVS Health Corp by three.2% in the first region. Leavell Investment Management Inc. Now owns 6,433 shares of the drugstore operator’s inventory worth $505,000 after buying an additional two hundred shares within the last region. Finally, IFP Advisors Inc raised its stake in CVS Health Corp by way of 17.1% inside the first sector. IFP Advisors Inc now owns 28,479 shares of the drugstore operator’s inventory valued at $2,236,000 after buying a further four,158 stocks in the remaining zone. Eighty one.29% of the stock is owned via institutional traders and hedge price range.
CVS Health Corp (NYSE CVS) opened at 79.Seventy one on Friday. The firm has a 50-day moving common of $seventy nine.22 and a two hundred day transferring common of $seventy nine.16. CVS Health Corp has a 1-12 months low of $sixty nine.30 and a 1-year high of $ninety eight.66. The company has a market cap of $eighty one.21 billion, a fee-to-income ratio of 16.Sixty two and a beta of 0.Eighty five.
CVS Health Corp (NYSE:CVS) remaining introduced its quarterly earnings effects on Tuesday, May 2nd. The pharmacy operator stated $1.17 profits in step with percentage for the quarter, beating the Zacks’ consensus estimate of $1.10 by $0.07. CVS Health Corp had a internet margin of 2.Sixteen% and a return on fairness of 10.Ninety seven%. The company had revenue of $forty four.51 billion for the quarter, in comparison to analyst estimates of $44.20 billion. During the identical sector in the preceding 12 months, the firm published $1.18 income in step with share. The business’s sales turned into up 3.0% on a year-over-12 months basis. Analysts count on that CVS Health Corp will post $5.87 earnings consistent with proportion for the cutting-edge economic year.
Several analysts recently commented on the stock. Jefferies Group LLC reissued a “hold” score and set a $82.00 goal charge on stocks of CVS Health Corp in a research notice on Friday. Vetr raised stocks of CVS Health Corp from a “purchase” score to a “sturdy-purchase” score and set a $88.Ninety seven target price for the employer in a research notice on Tuesday, June sixth. ValuEngine lowered stocks of CVS Health Corp from a “purchase” rating to a “keep” score in a studies word on Friday, June 2d. Evercore ISI reissued an “outperform” rating and set a $88.00 target price (up from $87.00) on shares of CVS Health Corp in a studies notice on Wednesday, May third. Finally, Tigress Financial assumed coverage on stocks of CVS Health Corp in a studies word on Thursday, April twenty seventh. They set a “purchase” score for the business enterprise. Eight research analysts have rated the stock with a maintain score, 11 have assigned a purchase rating and one has issued a strong buy rating to the employer’s stock. CVS Health Corp currently has a consensus rating of “Buy” and a consensus goal rate of $94.45.
In other CVS Health Corp news, EVP Troyen A. Brennan bought 23,849 shares of CVS Health Corp stock in a transaction that befell on Tuesday, March 21st. The stocks have been offered at an average charge of $seventy eight.73, for a total price of $1,877,631.77. Following the transaction, the executive vice president now owns 94,309 shares of the company’s inventory, worth $7,424,947.57. The sale changed into disclosed in a criminal filing with the SEC, which is available through this hyperlink. Also, EVP Andrew Sussman bought 14,104 shares of CVS Health Corp stock in a transaction that happened on Monday, March thirteenth. The shares have been sold at an average rate of $80.Forty, for a total transaction of $1,133,961.60. Following the crowning glory of the transaction, the executive vice president now directly owns 22,801 stocks in the business enterprise, worth approximately $1,833,200.Forty. The disclosure for this sale can be located right here. In the final ninety days, insiders sold forty three,982 stocks of company inventory really worth $three,491,502. Insiders personal 0.Fifty eight% of the organisation’s stock.
CVS Health Corp Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare corporation. The Company gives pharmacy care for the senior community thru Omnicare, Inc (Omnicare) and Omnicare’s long-time period care (LTC) operations, which consist of distribution of prescription drugs, associated pharmacy consulting and different ancillary offerings to persistent care facilities and different care settings.